TGM3 and neoplasm: In tumor immunology pathways, TGM3 was negatively correlated with a variety of immune-related pathways, such as NK cell-mediated cytotoxicity, T cell receptors, B cell receptors and toll-like receptor signaling pathways, in CESC, COAD, PRAD and OV.